SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Trading Update

22 Apr 2024 07:00

RNS Number : 3269L
Cerillion PLC
22 April 2024
 

AIM: CER

 Cerillion plc

("Cerillion" or the "Company")

 

Half Year Trading Update

 

Record Six Months

 

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the first six months of its current financial year ending 30 September 2024.

 

Results for the six-months ended 31 March 2024 are expected to set new highs for revenue and adjusted EBITDA. Revenue is expected to be approximately £22.5m (H1 2023: £20.5m) and adjusted EBITDA approximately £10.9m (H1 2023: £9.9m), both 10% higher year-on-year. Net cash at 31 March 2024 has increased to approximately £26.6m (31 March 2023: £23.6m), providing a very firm underpinning to the Company's strong balance sheet.  

 

The first half performance reflects ongoing strong demand from customers and the trading backdrop remains favourable. Telco digital transformation, the transition to Software-as-a-Service solutions and investment in enterprise software to achieve revenue and efficiency gains remain key features of the market, and consequently the Company's sales pipeline is strong. It includes a number of substantial potential new contracts, which are at various stages of the negotiation process. The Board believes that the Company remains well-placed to meet market expectations for the current financial year and beyond.

 

Notice of results

 

The Board expects to announce interim results on 13 May 2024, and will provide a further update on current trading at that time. 

 

 

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Ben Cryer, Matthew Hogg

 

 

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

About Cerillion

www.cerillion.com

 

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 80 customer installations across over 45 countries. Headquartered in London, Cerillion also has operations in India and Bulgaria.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZGMDRLMGDZG
Date   Source Headline
21st May 202112:26 pmRNSDirector/PDMR Shareholding
17th May 20214:33 pmRNSHolding(s) in Company
17th May 20217:00 amRNSInterim Results
19th Apr 20217:00 amRNSHalf Year Trading Update
29th Mar 20217:00 amRNSLargest Ever Contract Win
17th Mar 20215:47 pmRNSShare Purchase for Long-Term Incentive Plan
12th Mar 20215:43 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSMajor Channel Partner Yields First Contract
11th Feb 20215:14 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSPDMR Share Transfer
5th Feb 20219:31 amRNSResult of AGM
4th Feb 20213:00 pmRNSHolding(s) in Company
4th Feb 202112:09 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:13 pmRNSDirector/PDMR shareholding
30th Dec 20207:00 amRNSHolding(s) in Company
18th Dec 20206:07 pmRNSHolding(s) in Company
18th Dec 20201:17 pmRNSHolding(s) in Company
26th Nov 20208:53 amRNSHolding(s) in Company
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:37 pmRNSHolding(s) in Company
24th Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSFinal Results
18th Nov 20207:00 amRNSNew Three Year Managed Services Contract
6th Nov 20204:44 pmRNSHolding(s) in Company
6th Nov 20204:25 pmRNSHolding(s) in Company
6th Nov 20204:21 pmRNSHolding(s) in Company
27th Oct 20201:55 pmRNSHolding(s) in Company
20th Oct 202011:17 amRNSExercise of Options and Share Transfer
15th Oct 20207:00 amRNSTrading Update
16th Sep 20203:18 pmRNSHolding(s) in Company
15th Sep 20209:05 amRNSSecond Price Monitoring Extn
15th Sep 20209:00 amRNSPrice Monitoring Extension
15th Sep 20207:00 amRNSLargest Ever Contract Win
3rd Sep 202011:11 amRNSShare purchase for Long Term Incentive Plan
30th Jul 20203:08 pmRNSHolding(s) in Company
23rd Jul 20204:14 pmRNSHolding(s) in Company
1st Jul 20207:00 amRNSMajor Implementation Completed Remotely
10th Jun 20207:00 amRNSHolding(s) in Company
8th Jun 20205:43 pmRNSResult of Director Placing
8th Jun 20204:35 pmRNSProposed Director Placing
1st Jun 20207:00 amRNSDirector Retirement
11th May 20207:00 amRNSInterim Results
20th Apr 20207:00 amRNSHalf Year Trading Update
16th Mar 20207:00 amRNSChange of Adviser
10th Mar 20207:00 amRNSExercise of Options and Total Voting Rights
3rd Mar 20207:00 amRNSExercise of Options and Director/PDMR Shareholding
27th Feb 20204:45 pmRNSShare Purchase for Employee Share Option Scheme
26th Feb 20207:00 amRNSDirector/PDMR Shareholding
20th Feb 202011:52 amRNSHolding(s) in Company
13th Feb 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.